Ullet index:AnGes,Inc.:4563

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index AnGes,Inc. Go to web site 4563 Medicals 東証グロース December 1, 2000 2002.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

AnGes,Inc. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 26,103
plusdown
30,425
plusdown
38,635
plusup
32,680
plusup
12,055
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -7,438
plusup
-14,715
plusdown
-13,676
plusdown
-4,210
plusdown
-3,751
plus
Operating Cash Flow(OFC)Help -8,746
plusup
-11,214
plusup
-11,381
plusdown
-2,961
plusdown
-2,180
plus
Free Cash Flow(FCF)Help -9,102
plusup
-11,311
plusup
-11,535
plusdown
-9,925
plusdown
-3,430
plus
OFC - Net IncomeHelp 13
plusup
-40
plusdown
12
plusdown
42
plusdown
73
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -261.31%
plusdown
-204.04%
plusdown
-77.92%
plusdown
-34.87%
plusdown
-20.72%
plus
Current Assets / Amount of SalesHelp 2,187.70%
plusdown
8,195.71%
plusdown
22,767.88%
plusup
21,230.30%
plusup
3,220.40%
plus
Free Cash Revenue RatioHelp -5,949.87%
plusup
-16,867.31%
plusup
-17,982.51%
plusup
-24,814.49%
plusdown
-1,049.60%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

AnGes,Inc.

Company where related level is highHelp

DENKA SEIKEN Co.,Ltd.
KAINOS Laboratories,Inc.
SANTEN PHARMACEUTICAL CO.,LTD.
Toyama Chemical Co.,Ltd.
KISSEI PHARMACEUTICAL CO.,LTD.
Delta-Fly Pharma,Inc.
ROHTO PHARMACEUTICAL CO.,LTD.
Astellas Pharma Inc.
Noile-Immune Biotech Inc.
KYORIN Pharmaceutical Co., Ltd.